Search for: "Lilly v. Commissioner"
Results 1 - 20
of 65
Sort by Relevance
|
Sort by Date
29 Jan 2024, 4:35 pm
v=BxL9DRdk6Xc New Animation: End Hare Coursing In a world where compassion and empathy should be our guiding principles, it is disheartening to discover that some individuals derive enjoyment and profit from the suffering of innocent creatures. [read post]
3 May 2022, 4:18 am
Natasha Bertrand, Katie Bo Lillis, Jennifer Hansler, Alex Marquardt and Brad Lendon report for CNN. [read post]
8 Dec 2021, 11:27 am
However, CA RIAs can avoid these additional requirements by engaging a PCAOB-registered auditor to prepare and distribute audited financial statements to all beneficial owners of the pooled investment vehicle, and the Commissioner of the California Department of Financial Protection and Innovation (“DFPI”). [read post]
8 Dec 2021, 7:27 am
However, CA RIAs can avoid these additional requirements by engaging a PCAOB-registered auditor to prepare and distribute audited financial statements to all beneficial owners of the pooled investment vehicle, and the Commissioner of the California Department of Financial Protection and Innovation (“DFPI”). [read post]
22 Dec 2020, 9:43 am
However, CA RIAs can avoid these additional requirements by engaging a PCAOB-registered auditor to prepare and distribute audited financial statements to all beneficial owners of the pooled investment vehicle, and the Commissioner of the California Department of Financial Protection and Innovation (“DFPI”). [read post]
16 Apr 2020, 4:55 am
**** Digital Asset Matters SEC Commissioner Proposes 3-Year Safe Harbor Period for Crypto Token Sales. [read post]
9 Mar 2020, 1:21 pm
FDA and FTC Approaches to Help Ensure Truthful and Non‐misleading Advertising and Promotional Communications Lowell Schiller, Principal Associate Commissioner for Policy, FDA: have seen troubling communications suggesting biosimilars are less safe/less effective than reference products or that there may be clinically meaningful differences b/t them when biosimilars can’t be approved unless there are no clinically meaningful differences. [read post]
19 Nov 2019, 12:01 am
Speakers will touch upon a variety of developments in the UK and across Europe, including the doctrine of equivalents following Actavis v Lilly, plausibility and requirements for data in patent applications and recent developments in relation to injunctions, as well as providing an update on case law from the EPO. [read post]
30 Jul 2019, 9:04 am
Ieva Giedrimaite discusses the UK’s Information Commissioner’s Office new guidance on the use of cookies and similar technologies for storing information, and accessing information stored, on a user's equipment, such as a computer or mobile device. [read post]
11 Jan 2019, 4:00 am
In the UK, the Supreme Court in 2017 released its decision in Actavis UK Ltd v Eli Lilly & Co [2017] UKSC 48 which allowed for variants in claim construction. [read post]
21 Dec 2018, 9:14 am
R (Derry) v Commissioners for HMRC was heard on 12 December 2018. [read post]
10 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
3 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
26 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
19 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
12 Jun 2017, 6:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
5 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
23 May 2017, 2:35 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
22 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
15 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
